Team
Patrick Aisher
Patrick Aisher is a serial entrepreneur who has invested in the life sciences industry since 1997. He has focused on biomedical technology companies developing medical devices, biopharmaceuticals, and healthcare services, making over 40 direct investments.
Patrick has a broad portfolio, including various successful NASDAQ exits, two trade sale exits at $40M (KB Medical to Globus in 2018) and $150M+ (Medina Medical to Medtronic in 2016), and two exits via international licensing transactions valued at $350M+. He is a partner in a $200M venture fund for private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. Over the years, Patrick has cultivated strong relationships with key industry players, positioning himself as a significant figure in the venture capital landscape.
Patrick is a Director of Aleva Neurotherapeutics SA and PreComb Therapeutics AG, and has identified and invested in early-stage spin-off opportunities from universities in Barcelona, Zurich, Oxford, Boston, Stanford, Northeastern, Texas, NYU, Lausanne, and Geneva. His commitment to fostering innovation in the life sciences sector is reflected in his active involvement in mentoring and supporting emerging entrepreneurs, as well as his participation in various industry conferences and panels.
